Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.
Dorjee K, Sadutshang TD, Rana RS, Topgyal S, Phunkyi D, Choetso T, Chodon T, Parmar M, Singla R, Paster Z, Chaisson RE, Kaushal KC. Dorjee K, et al. Among authors: chaisson re. Indian J Tuberc. 2020 Jan;67(1):59-64. doi: 10.1016/j.ijtb.2019.08.005. Epub 2019 Aug 17. Indian J Tuberc. 2020. PMID: 32192619 Free PMC article.
Tuberculosis drug resistance: a global threat.
Nachega JB, Chaisson RE. Nachega JB, et al. Among authors: chaisson re. Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S24-30. doi: 10.1086/344657. Clin Infect Dis. 2003. PMID: 12516027
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW; Tuberculosis Trials Consortium. Dorman SE, et al. J Infect Dis. 2012 Oct 1;206(7):1030-40. doi: 10.1093/infdis/jis461. Epub 2012 Jul 30. J Infect Dis. 2012. PMID: 22850121 Clinical Trial.
High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children.
Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, J Bonomo E, Paster Z, Chaisson RE. Dorjee K, et al. Among authors: chaisson re. Clin Infect Dis. 2019 Aug 16;69(5):760-768. doi: 10.1093/cid/ciy987. Clin Infect Dis. 2019. PMID: 30462191 Free PMC article.
Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
Dorjee K, Topgyal S, Tsewang T, Tsundue T, Namdon T, Bonomo E, Kensler C, Lhadon D, Choetso T, Nangsel T, Dolkar T, Tsekyi T, Dorjee C, Phunkyi D, Sadutshang TD, Paster Z, Chaisson RE. Dorjee K, et al. Among authors: chaisson re. PLoS Med. 2021 Jan 19;18(1):e1003502. doi: 10.1371/journal.pmed.1003502. eCollection 2021 Jan. PLoS Med. 2021. PMID: 33465063 Free PMC article.
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.
Tsundue T, Namdon T, Tsewang T, Topgyal S, Dolma T, Lhadon D, Choetso T, Woesal T, Yangkyi T, Gupta A, Peters D, Paster Z, Phunkyi D, Sadutshang TD, Chaisson RE, Dorjee K. Tsundue T, et al. Among authors: chaisson re. BMJ Glob Health. 2022 May;7(5):e008271. doi: 10.1136/bmjgh-2021-008271. BMJ Glob Health. 2022. PMID: 35609920 Free PMC article.
447 results